Miroculus
Miroculus develops and manufactures non-invasive tools for molecular data gathering, analysis, and interpretation. Its core technology is digital microfluidics, enabling automation and miniaturization of genomic protocols like NGS library prep and synthetic biology in a compact, cartridge-based system. The company serves academic institutions, pharmaceuticals, biotechnology, and diagnostics companies, empowering them to detect and monitor diseases at the molecular level.
Top Regions
Top Stages
1 past transactions
Kapplex
Acquisition in 2016
Kapplex Inc. is a Toronto-based company that designs and manufactures advanced point-of-care diagnostic platforms. Established in 2012, the company focuses on enabling the rapid and accurate diagnosis of common infectious diseases in various healthcare settings, including retail clinics, doctor's offices, urgent care units, and emergency rooms. Kapplex leverages a proprietary Digital Microfluidic (DMF) technology, originally developed in a University of Toronto lab, which simplifies and automates traditional sample preparation and analysis processes on an economical, single-chip device. This innovative approach aims to enhance clinical decision-making at the point of care, ultimately improving treatment outcomes while reducing healthcare costs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.